MDNA Life Sciences
2054 Vista Parkway
Suite 400
West Palm Beach
Florida
33411
United States
Tel: 844-321-6362
Website: http://mdnalifesciences.com/
Email: info@mdnalifesciences.com
About MDNA Life Sciences
MDNA Life Sciences, Inc., is pioneering the development of molecular tests based on the mitochondrial genome in order to improve clinical insight and therapeutic decisions that affect patients worldwide. The unique structural and functional characteristics of mitochondrial DNA (mtDNA) make it a highly attractive system for biomarker discovery, early disease detection, monitoring, risk assessment and therapeutic targeting.YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Chris Mitton
CDO: Jennifer Creed
CSO: Andrew Harbottle
SCIENCE:
Please click here for MDNA Life Sciences' science.
PIPELINE:
Please click here for MDNA Life Sciences' pipeline.
6 articles about MDNA Life Sciences
-
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
1/8/2024
Aditxt, Inc. today announces that the Company and its subsidiary, Pearsanta, Inc. (“Pearsanta”), has acquired MDNA Life Sciences Inc.’s (“MDNA”) proprietary, early disease and cancer detection platform.
-
Breaking News - Biomarker found for Endometriosis - Can detect 9/10 Cases
4/2/2019
World’s first blood test for endometriosis can detect up to 9 out of 10 cases
-
MDNA Life Sciences Begins Global Roll-Out With Appointment Of Distribution Partner In South Korea
2/20/2017
-
MDNA Life Sciences Release: Prostate Core Mitomic Test Significantly Reduces Unnecessary Biopsies, Improves Cancer Detection, New Study Says.
1/11/2017
-
MDNA Life Sciences Selects Phi Life Sciences As Its First US Distribution Partner For Its New Liquid Biopsy Test For Prostate Cancer
11/30/2016
-
MDNA Life Sciences And University of Oxford To Collaborate To Develop A Mitochondrial Biomarker Blood-Based Diagnostic For Endometriosis
11/1/2016